Isquemia miocárdica: conceptos básicos, diagnóstico e implicaciones clínicas. Tercera parte

Felker, 2002, A standardized definition of ischemic cardiomyopathy for use in clinical research, J Am Coll Cardiol., 39, 210, 10.1016/S0735-1097(01)01738-7 He, 2001, Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study, Arch Intern Med., 161, 996, 10.1001/archinte.161.7.996 Allman, 2002, Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis, J Am Coll Cardiol., 39, 1151, 10.1016/S0735-1097(02)01726-6 Desideri, 2005, The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction, J Am Coll Cardiol., 46, 1264, 10.1016/j.jacc.2005.06.057 Pagley, 1997, Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability, Circulation., 96, 793, 10.1161/01.CIR.96.3.793 Tillisch, 1986, Reversibility of cardiac wall-motion abnormalities predicted by positron tomography, N Engl J Med., 314, 884, 10.1056/NEJM198604033141405 Buckley, 2011, Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability, Circulation., 123, 444, 10.1161/CIRCULATIONAHA.109.903369 Camici, 2008, Stunning, hibernation, and assessment of myocardial viability, Circulation., 117, 103, 10.1161/CIRCULATIONAHA.107.702993 Bax, 2002, Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization, J Nucl Med., 43, 795 Bax, 2003, Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting, Am J Cardiol., 92, 1, 10.1016/S0002-9149(03)00454-5 Hanekom, 2005, Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization, Circulation., 112, 3892, 10.1161/CIRCULATIONAHA.104.489310 Kim, 2000, The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, N Engl J Med., 343, 1445, 10.1056/NEJM200011163432003 Stipac, 2013, Effect of myocardial revascularisation on left ventricular systolic function in patients with and without viable myocardium: should non-viable segments be revascularised?, Heart, 99, 1749, 10.1136/heartjnl-2013-304288 Velazquez, 2011, Coronary-artery bypass surgery in patients with left ventricular dysfunction, N Engl J Med., 364, 1607, 10.1056/NEJMoa1100356 Bonow, 2011, Myocardial viability and survival in ischemic left ventricular dysfunction, N Engl J Med., 364, 1617, 10.1056/NEJMoa1100358 Cleland, 2003, Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial, Lancet., 362, 14, 10.1016/S0140-6736(03)13801-9 Seghatol, 2004, Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol., 93, 854, 10.1016/j.amjcard.2003.12.023 Shah, 2003, Survival after myocardial revascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study, J Thorac Cardiovasc Surg., 126, 1320, 10.1016/S0022-5223(03)00809-2 Gerber, 2012, Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy, J Am Coll Cardiol., 59, 825, 10.1016/j.jacc.2011.09.073